Uber Technologies Inc 0.875% | - | 3.70% | - | - | 550,000 |
Bridgebio Pharma Inc 1.75% | - | 3.70% | - | - | 400,000 |
Halozyme Therapeutics Inc 0.875% | - | 2.88% | - | - | 375,000 |
HAT Holdings I LLC and HAT Holdings II LLC 3.75% | - | 2.82% | - | - | 350,000 |
Revolution Medicines Inc 0.5% | - | 2.72% | - | - | 370,000 |
Vishay Intertechnology, Inc. 2.25% | - | 2.56% | - | - | 350,000 |
Procore Technologies Inc 0% | - | 2.49% | - | - | 450,000 |
Nova Ltd 0% | - | 2.49% | - | - | 325,000 |
Travere Therapeutics Inc 0.5% | - | 2.45% | - | - | 350,000 |
TransMedics Group Inc. 1.5% | - | 2.37% | - | - | 350,000 |
Miller Investment Trust - Miller Convertible Total Return ETF is an exchange traded fund launched and managed by Wellesley Asset Management, Inc. The fund invests in fixed income markets of the United States. It seeks to invest in convertible bonds issued by corporates with maturities of less than 7 years. The fund employs a combination of fundamental and quantitative analysis while focusing on factors such as issuer’s creditworthiness to create its portfolio. Miller Investment Trust - Miller Convertible Total Return ETF was formed on March 24,2026 and is domiciled in the United States.